Phase-I study MEDI-534, of a live, attenuated intranasal vaccine against respiratory syncytial virus and parainfluenza-3 virus in seropositive children (Q45384017)

From Wikidata
Jump to navigation Jump to search
scientific article published in July 2009
edit
Language Label Description Also known as
English
Phase-I study MEDI-534, of a live, attenuated intranasal vaccine against respiratory syncytial virus and parainfluenza-3 virus in seropositive children
scientific article published in July 2009

    Statements

    Phase-I study MEDI-534, of a live, attenuated intranasal vaccine against respiratory syncytial virus and parainfluenza-3 virus in seropositive children (English)
    Margarita Gomez
    Filip Dubovsky
    Conor Knightly
    Wen Zeng
    Genevieve Losonsky
    1 July 2009
    655-658

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit